Fluticasone/Salmeterol Combination Confers Benefits in People With Asthma Who Smoke
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Systemic bioavailability of hydrofluoroalkane (HFA) formulations of fluticasone/salmeterol in healthy volunteers via pMDI alone and spacerBritish Journal of Clinical Pharmacology, 2010
- Determinants of response to fluticasone propionate and salmeterol/fluticasone propionate combination in the Gaining Optimal Asthma controL studyJournal of Allergy and Clinical Immunology, 2007
- Standardisation of spirometryEuropean Respiratory Journal, 2005
- Smoking cessation improves both direct and indirect airway hyperresponsiveness in COPDEuropean Respiratory Journal, 2004
- Effects of fluticasone vs. fluticasone/salmeterol on airway calibre and airway hyperresponsiveness in mild persistent asthmaBritish Journal of Clinical Pharmacology, 2003
- Sustained reduction in bronchial hyperresponsiveness with inhaled fluticasone propionate within three days in mild asthma: time course after onset and cessation of treatmentThorax, 2003
- Airway-stabilizing effect of long-acting 2-agonists as add-on therapy to inhaled corticosteroidsQJM: An International Journal of Medicine, 2003
- Relationships of active smoking to asthma and asthma severity in the EGEA studyEuropean Respiratory Journal, 2000
- Effect of Inhaled Formoterol and Budesonide on Exacerbations of AsthmaNew England Journal of Medicine, 1997
- Relationship between the inflammatory infiltrate in bronchial biopsy specimens and clinical severity of asthma in patients treated with inhaled steroids.Thorax, 1996